Bitfarms (BITF) files Q2 2025 interim financials and MD&A

Bitfarms Ltd. submitted a Form 6-K reporting the inclusion of its Interim Condensed Consolidated Financial Statements and Management's Discussion & Analysis for the three and six months ended June 30, 2025.

Rhea-AI Filing Summary

Bitfarms Ltd. submitted a Form 6-K reporting the inclusion of its Interim Condensed Consolidated Financial Statements and Management's Discussion & Analysis for the three and six months ended June 30, 2025. The filing lists Exhibits 99.1–99.4, which also include interim CEO and CFO certifications to accompany the interim filings. The report indicates the company files annual reports under Form 40-F and provides the registrant's principal office in Toronto, Ontario, Canada. This filing supplies investors with the company’s formal interim financial package and related management commentary for the stated period.

Positive

• Interim condensed consolidated financial statements filed for the three and six months ended June 30, 2025
• Management's Discussion & Analysis (MD&A) included, providing management commentary alongside the financials
• CEO and CFO interim certifications (Exhibits 99.3 and 99.4) are included, indicating attestation to the interim filings
• Form 40-F indicated as the company’s annual-reporting form, clarifying reporting status as a foreign issuer

Negative

• None.

Insights

Financial Analyst

TL;DR Routine interim disclosure: Q2 interim financials and MD&A filed; no additional material events described.

The Form 6-K lists the company’s interim condensed consolidated financial statements and accompanying MD&A for the three and six months ended June 30, 2025, which are standard periodic disclosures. Exhibits include CEO and CFO interim certifications, indicating the company has provided management’s discussion and signed attestations alongside the financials. The filing itself does not describe any new transactions, financing, or operational changes beyond making these documents available to investors.

Corporate Governance Expert

TL;DR Disclosure and attestation present: CEO/CFO certifications accompany interim filings, supporting formal compliance with interim reporting.

The exhibits listed (99.1–99.4) pair the interim financial statements and MD&A with CEO and CFO interim certificates, a governance standard that supports the integrity of the interim disclosures. The Form 6-K also notes Form 40-F as the company’s annual-reporting route, aligning with cross-border reporting expectations for a foreign private issuer. The submission appears to be a procedural compliance filing without described governance changes or material corporate actions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bitfarms (BITF) file in this Form 6-K?

The Form 6-K lists the Interim Condensed Consolidated Financial Statements, the Management's Discussion & Analysis for the three and six months ended June 30, 2025, and interim CEO and CFO certifications.

Which reporting form does Bitfarms use for its annual reports?

The filing shows Bitfarms indicates it files annual reports under Form 40-F.

Are the interim financial statements and MD&A incorporated by reference elsewhere?

Yes. Exhibits 99.1 and 99.2 are stated to be deemed incorporated by reference into the company’s registration statements on Form F-10 and Form S-8.

For which period are the interim financial statements provided?

The interim condensed consolidated financial statements and MD&A cover the three and six months ended June 30, 2025.

Does the Form 6-K disclose any material transactions or corporate actions?

No material transactions or corporate actions are described in the Form 6-K; it lists exhibits related to interim reporting and certifications.

Where is Bitfarms’ principal executive office located?

The registrant’s principal office is located in Toronto, Ontario, Canada.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2025 - 07:47 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-40370

BITFARMS LTD.

(Translation of registrant’s name into English)

110 Yonge Street, Suite 1601, Toronto, Ontario, Canada M5C 1T4

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒

DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K

Exhibits 99.1 and 99.2 shall be deemed to be incorporated by reference as exhibits to the Registration Statements of Bitfarms Ltd. on Form F-10 (File No. 333-272989) and Form S-8 (File No. 333-278868 and File No. 333-285894).

See the Exhibits listed below.

Exhibits
Exhibit No.		Description
99.1		Interim Condensed Consolidated Financial Statements for the three and six months ended June 30, 2025
99.2		Management’s Discussion & Analysis for the three and six months ended June 30, 2025
99.3		CEO Certification of Interim Filings - Interim Certificate dated August 12, 2025
99.4		CFO Certification of Interim Filings - Interim Certificate dated August 12, 2025

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BITFARMS LTD.
	By:	/s/ Ben Gagnon
		Name:	Ben Gagnon
		Title:	Chief Executive Officer

Date: August 12, 2025

2